NAll news

All news

Wednesday142 items

  3. Testing Catalog
    AI score60

    OpenAI Acquires Orchestra Bio to Advance Life Sciences Rosalind Models and Tools

    OpenAI announced the acquisition of Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. The two sides will continue development based on OpenAI's Rosalind models and tools for life sciences research, in order to streamline these processes and help new treatments reach patients sooner.

    Quoted postOpenAI · @OpenAI

    We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://t.co/vi51OhznQn

    #Industry news#OpenAI

  4. Rohan Paul
    AI score60

    Meta's AI agent Muse reaches 10.2 million US downloads in 40 days since launch

    Meta's AI agent Muse reached 10.2 million US downloads within 40 days, a pace only 11 apps have ever achieved in history, most of which are mobile games. Its US 7-day retention rate is 30% and 14-day retention rate is 23%, compared with competitor averages of 19% and 16% respectively; daily active users reached 2.5 million on October 16, up 15% in a week, but still less than a quarter of US downloads.

    #English text is being prepared.#Agents#Meta

  7. Mark Chen
    AI score65

    OpenAI Acquires Orchestra Bio to Expand AI-Assisted Drug Discovery

    OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. OpenAI's head of research Mark Chen said the two sides will build on Rosalind, the AI models and tools for life sciences research, to streamline these processes and help new treatments reach patients sooner.

    Quoted postOpenAI · @OpenAI

    We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://t.co/vi51OhznQn

    #Industry news#OpenAI

  8. TechCrunch AI
    AI score73

    Meta's AI app Muse reaches 10.2 million US downloads 40 days after launch

    Meta's AI app Muse has accumulated 10.9 million downloads since launching in September, including 10.2 million in the US market, making it one of the few apps to reach that scale within 40 days of launch. Sensor Tower data shows that Muse's 7-day retention rate in the US is 30% and its 14-day retention rate is 23%, above the averages of 19% and 16% for ChatGPT, Claude, and Grok; on October 16, its daily active users reached 2.5 million for the first time, up 15% month over month. In October, Meta allocated 39% of its advertising spend to promoting Muse, up from 23% the previous month.

    #Industry news#English text is being prepared.#English text is being prepared.

  9. TechCrunch AI
    AI score51

    Bloomberg says Schmidt holds about 1% stake in Anthropic

    According to Bloomberg, former Google CEO Schmidt participated in Anthropic's Series A funding round in 2021, investing tens of millions of dollars, and currently holds about 1% of the company. The report says this proportion is about half of the 2% held by co-founder and CEO Dario Amodei; Anthropic is widely expected to go public before the end of the year, with a maximum valuation expectation of $2 trillion, at which point the value of Schmidt's stake could increase by as much as $20 billion. Neither Schmidt nor Anthropic immediately responded to requests for comment.

    Same story · 2 reports

    #Industry news#Anthropic

  13. TechCrunch AI
    AI score62

    Anthropic proposes draft AI safety bill that would block model releases when risk of 50+ deaths exists

    Anthropic has pitched a draft AI safety bill to Congress that would allow a model's release to be blocked when it poses a foreseeable, imminent risk that could cause 50 or more deaths or more than $1 billion in property damage. The risk must stem from the manufacture of bioweapons, the model evading its developer's control, or cyberattacks. The draft requires an independent evaluator registered with the U.S. Department of Commerce to determine the risk; the evaluator must report within 72 hours, after which the Commerce Department would apply to a Washington, D.C., judge for an order to halt the release. Federal agencies would not be allowed to decide on blocking a release themselves.

    #English text is being prepared.#Anthropic#Safety / alignment

  17. 36Kr · AI
    AI score76

    OpenAI advances roughly $30 billion funding round, aiming to lock in investors ahead of Anthropic's IPO

    According to Reuters, OpenAI is accelerating a roughly $30 billion funding round, targeting a valuation above $1.4 trillion, seeking to lock in investors before Anthropic's expected mid-November IPO; existing investors including SoftBank and Abu Dhabi's MGX are in talks to participate. OpenAI told investors that growth accelerated after the release of GPT-6 Astra, with annualized revenue already at $50 billion and expected to rise to $70 billion by year-end; Anthropic said its third-quarter revenue rose from $11.6 billion to $16.8 billion, but slowing month-over-month growth has raised valuation concerns. The two also differ on revenue recognition: OpenAI recognizes revenue on a net basis and has accused Anthropic of recognizing revenue on a gross basis under third-party cloud vendor contracts.

    Same story · 2 reports

    #Industry news#OpenAI#Anthropic